Terminal sialic acid residues on human glycophorin A are recognized by porcine Kupffer cells

Transplantation

Volumn 80, Issue 3, 2005, Pages 344-352

  Burlak, Christopher ^a,b   Twining, Lisa M ^a   Rees, Michael A ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Extracorporeal perfusion; Glycophorin A; N acetylneuraminic acid; Sialic acid; Xenogeneic

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; CARBOHYDRATE; EPITOPE; ERYTHROCYTE CR 51; GLYCOPHORIN A; GLYCOPROTEIN; GLYCOSIDASE; HYALURONIC ACID; LACTOSE; LIGAND; MONOSACCHARIDE; MUCIN; N ACETYLNEURAMINIC ACID; NEURAMINIC ACID; NEURAMINYL LACTOSE; O ANTIGEN; PROTEOGLYCAN; PROTEOGLYCAN N LINKED GLYCOSIDASE F; RECEPTOR; SIALIC ACID; SIALIDASE A; SIALIDASE INHIBITOR; TRISACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; BLOOD GROUP MNSS SYSTEM; DILUTION; ERYTHROCYTE; GRAFT REJECTION; HUMAN; HUMAN CELL; KUPFFER CELL; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; QUANTITATIVE ERYTHROCYTE ROSETTE ASSAY; ROSETTE FORMATION; SWINE; XENOGRAFT; XENOTRANSPLANTATION;

ABO BLOOD-GROUP SYSTEM; ANIMALS; CARBOHYDRATES; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; GLYCOPHORIN; GLYCOPROTEINS; GRAFT REJECTION; HUMANS; HYALURONIC ACID; KUPFFER CELLS; LACTOSE; MONOSACCHARIDES; MUCINS; N-ACETYLNEURAMINIC ACID; NEURAMINIDASE; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; PROTEIN BINDING; SPECIES SPECIFICITY; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 23744432758     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000162974.94890.9F     Document Type: Article

References (48)

1. Kolber-Simonds D, Lai L, Watt SR, et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci U S A 2004; 101(19): 7335.
2. Dor FJ, Tseng YL, Cheng J, et al. alpha1,3-Galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-Gal antibodies. Transplantation 2004; 78(1): 15.
3. Rees MA. A novel role for lectins in xenotransplantation. Xenotransplantation 2005; 12(1): 7.
4. 3a. Burlak et al. Transplantation, in press.
5. Dahr W, Wilkinson S, Issitt PD, et al. High frequency antigens of human erythrocyte membrane sialoglycoproteins, III. Studies on the EnaFR, Wrb and Wra antigens. Biol Chem Hoppe Seyler 1986; 367( 10): 1033.
6. Gardner B, Parsons SF, Merry AH, et al. Epitopes on sialoglycoprotein alpha: evidence for heterogeneity in the molecule. Immunology 1989; 68(2): 283.
7. Bretscher MS. A major protein which spans the human erythrocyte membrane. J Mol Biol 1971; 59(2): 351.
8. Dahr W, Uhlenbruck G, Janssen E, et al. Heterogeneity of human cell membrane sialoglycoproteins. Blut 1976; 32(3): 171.
9. Tomita M, Marchesi VT. Amino-acid sequence and oligosaccharide attachment sites of human erythrocyte glycophorin. Proc Natl Acad Sci U S A 1975; 72(8): 2964.
10. Tomita M, Furthmayr H, Marchesi VT. Primary structure of human erythrocyte glycophorin A. Isolation and characterization of peptides and complete amino acid sequence. Biochemistry 1978; 17(22): 4756.
11. Pisano A, Redmond JW, Williams KL, et al. Glycosylation sites identified by solid-phase Edman degradation: O-linked glycosylation motifs on human glycophorin A. Glycobiology 1993; 3(5): 429.
12. Thomas DB, Winzler RJ. Structural studies on human erythrocyte glycoproteins. Alkali-labile oligosaccharides. J Biol Chem 1969; 244(21): 5943.
13. Lisowska E, Duk M, Dahr W. Comparison of alkal-labile oligosaccharide chains of M and N blood-group glycopeptides from human erythrocyte membrane. Carbohydr Res 1980; 79(1): 103.
14. Fukuda K, Honma K, Manabe H, et al. Alkali-labile oligosaccharide units of a sialoglycoprotein from rabbit erythrocyte membranes. Biochim Biophys Acta 1987; 926(2): 132.
15. Adamany AM, Blumenfeld OO, Sabo B, et al. A carbohydrate structural variant of MM glycoprotein (glycophorin A). J Biol Chem 1983; 258(19): 11537.
16. Takasaki S, Yamashita K, Kobata A. The sugar chain structures of ABO blood group active glycoproteins obtained from human erythrocyte membrane. J Biol Chem 1978; 253(17): 6086.
17. Blanchard D, Cartron JP, Fournet B, et al. Primary structure of the oligosaccharide determinant of blood group Cad specificity. J Biol Chem 1983; 258(12): 7691.
18. Yoshima H, Furthmayr H, Kobata A. Structures of the asparagine-linked sugar chains of glycophorin A. J Biol Chem 1980; 255(20): 9713.
19. Vaysse J, Gattegno L, Bladier D, et al. Adhesion and erythrophagocytosis of human senescent erythrocytes by autologous monocytes and their inhibition by beta-galactosyl derivatives. Proc Natl Acad Sci U S A 1986; 83(5): 1339.
20. Schlepper-Schafer J, Kolb-Bachofen V. Red cell aging results in a change of cell surface carbohydrate epitopes allowing for recognition by galactose-specific receptors of rat liver macrophages. Blood Cells 1988; 14(1): 259.
21. Mohr M, Kolb H, Kolb-Bachofen V, et al. Recognition of xenogeneic erythrocytes: the GalNAc/Gal-partide receptor of rat liver macrophages mediates or participates in recognition. Biol Cell 1987; 60(3): 217.
22. Rees MA, Butler AJ, Davies HF, et al. Porcine livers perfused with human blood mount a graft-versus-"host" reaction. Transplantation 2002; 73(9): 1460.
23. Rees MA, Butler AJ, Brons IG, et al. Evidence of macrophage receptors capable of direct recognition of xenogeneic epitopes without opsonization. Xenotransplantation 2005; 12(1): 13.
24. Morrissey GJ, Gravelle DR, Lo J, et al. Chromium-51 labeling of sheep red blood cells. Lab Anim Sci 1992; 42(1): 70.
25. Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 1963; 100: 119.
26. Marchesi VT, Andrews EP. Glycoproteins: isolation from cell membranes with lithium diiodosalicylate. Science 1971; 174(15): 1247.
27. Marchesi VT, Tillack TW, Jackson RL, et al. Chemical characterization and surface orientation of the major glycoprotein of the human erythrocyte membrane. Proc Natl Acad Sci U S A 1972; 69(6): 1445.
28. Aminoff D, Morrow MP. Effect of sialidase on blood group specificity of hog submaxillary glycoproteins. FEBS Lett 1970; 8(6): 353.
29. Varki A. Sialic acids as ligands in recognition phenomena. Faseb J 1997; 11(4): 248.
30. Wasylnka JA, Simmer MI, Moore MM. Differences in sialic acid density in pathogenic and non-pathogenic Aspergillus species. Microbiology 2001; 147(Pt 4): 869.
31. Galili U, Buehler J, Shohet SB, et al. The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by cross-reactivity between natural anti-Gal and anti-B antibodies. J Exp Med 1987; 165(3): 693.
32. Schlepper-Schafer J, Kolb-Bachofen V, Kolb H. Analysis of lectin-dependent recognition of desialylated erythrocytes by Kupffer cells. Biochem J 1980; 186(3): 827.
33. Siebert HC, Andre S, Reuter G, et al. Comparison between intact and desialylated human serum amyloid P component by laser photo CI-DNP (chemically induced dynamic nuclear polarization) technique: an indication for a conformational impact of sialic acid. Glycoconj J 1997; 14(8): 945.
34. Varki A. Loss of N-glycolylneuraminic acid in humans: mechanisms, consequences, and implications for hominid evolution. Am J Phys Anthropol 2001; Suppl 33:54.
35. Malykh YN, Schauer R, Shaw L. N-Glycolylneuraminic acid in human tumours. Biochimie 2001; 83(7): 623.
36. Hueso P, Reglero A, Rodrigo M, et al. Isolation and characterization of gangliosides from pig lymphocytes. Biol Chem Hoppe Seyler 1985; 366(2): 167.
37. Sato C, Kitajima K, Inoue S, et al. Identification of oligo-N-glycolyl-neuraminic acid residues in mammal-derived glycoproteins by a newly developed immunochemical reagent and biochemical methods. J Biol Chem 1998; 273(5): 2575.
38. Malykh YN, King TP, Logan E, et al. Regulation of N-glycolylneuraminic acid biosynthesis in developing pig small intestine. Biochem J 2003; 370(Pt 2): 601.
39. Rees MA, Butler AJ, Negus MC, et al. Classical pathway complement destruction is not responsible for the loss of human erythrocytes during porcine liver perfusion. Transplantation 2004; 77(9): 1416.
40. Crocker PR, Varki A. Siglecs, sialic acids and innate immunity. Trends Immunol 2001; 22(6): 337.
41. May AP, Robinson RC, Vinson M, et al. Crystal structure of the N-terminal domain of sialoadhesin in complex with 3′ sialyllactose at 1.85 A resolution. Mol Cell 1998; 1(5): 719.
42. Crocker PR, Gordon S. Properties and distribution of a lectin-like hemagglutinin differentially expressed by murine stromal tissue macrophages. J Exp Med 1986; 164(6): 1862.
43. Angata T, Varki A. Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem Rev 2002; 102(2): 439.
44. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 2000; 290(5489): 84.
45. Muchmore EA, Diaz S, Varki A. A structural difference between the cell surfaces of humans and the great apes. Am J Phys Anthropol 1998; 107(2): 187.
46. Dorling A, Monk N, Lechler R. HLA-G inhibits the transendothelial cell migration of human NK cells: a strategy for inhibiting xenograft rejection. Transplant Proc 2000; 32(5): 938.
47. Forte P, Pazmany L, Matter-Reissmann UB, et al. HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells. J Immunol 2001; 167(10): 6002.
48. Sharland A, Patel A, Lee JH, et al. Genetically modified HLA class I molecules able to inhibit human NK cells without provoking alloreactive CD8+ CTLs. J Immunol 2002; 168(7): 3266.